4D Molecular Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
4D Molecular Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2018 to Q4 2023.
  • 4D Molecular Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $11.9M, a 43.9% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $11.9M +$3.63M +43.9% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $8.27M +$2.69M +48.1% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $5.59M +$2.22M +65.9% Dec 31, 2021 10-K 2024-02-29
Q4 2020 $3.37M +$1.8M +115% Dec 31, 2020 10-K 2023-03-15
Q4 2019 $1.57M +$907K +138% Dec 31, 2019 10-K 2022-03-28
Q4 2018 $659K Dec 31, 2018 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.